Mulroy Michael H.

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$32,440.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Mulroy Michael H.

According to the SEC Form 4 filings, Mulroy Michael H., being in a position of

  1. director at Lineage Cell Therapeutics, Inc.,
    оver the last 12 months, has bought 40000 shares for $22,640, and sold 0 shares,
    over all time since 2022-03-24, has bought 47000 shares for $32,440, and sold 0 shares.

The largest purchase of all time was on 2024-11-22 and amounted to 40000 shares of Lineage Cell Therapeutics, Inc. for $22,640.

Biography of Mulroy Michael H.

No biography is available at this moment.

2024-11-22PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
40,000
0.0237%
$0.57$22,640+13.36%
2022-03-24PurchaseLineage Cell Therapeutics, Inc.
LCTX
7,000
0.004%
$1.40$9,800-4.86%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.